|
AbbVie
|
174.20 |
|
1.47 |
0.85% |
5.77% |
2025-04-18 |
|
Acadia Pharmaceuticals
|
14.73 |
|
0.16 |
1.10% |
-13.71% |
2025-04-17 |
|
Agios Pharmaceuticals
|
27.66 |
|
0.52 |
1.92% |
-6.01% |
2025-04-17 |
|
ALKERMES
|
27.00 |
|
-0.20 |
-0.74% |
13.64% |
2025-04-17 |
|
Alnylam Pharmaceuticals
|
234.56 |
|
4.06 |
1.76% |
61.59% |
2025-04-17 |
|
Amgen
|
276.99 |
|
-5.85 |
-2.07% |
5.41% |
2025-04-17 |
|
Biogen
|
118.54 |
|
3.28 |
2.84% |
-37.78% |
2025-04-17 |
|
BioMarin Pharmaceutical
|
59.17 |
|
0.35 |
0.60% |
-34.31% |
2025-04-17 |
|
Cytokinetics
|
39.48 |
|
0.33 |
0.84% |
-41.07% |
2025-04-17 |
|
Dynavax Technologies
|
10.31 |
|
-0.34 |
-3.19% |
-9.08% |
2025-04-17 |
|
Exelixis
|
36.19 |
|
0.04 |
0.11% |
60.92% |
2025-04-17 |
|
Gilead Sciences
|
105.00 |
|
0.51 |
0.49% |
58.75% |
2025-04-18 |
|
Halozyme Therapeutics
|
58.79 |
|
-0.03 |
-0.05% |
55.49% |
2025-04-17 |
|
Incyte
|
58.21 |
|
0.48 |
0.83% |
10.27% |
2025-04-17 |
|
Ionis Pharmaceuticals
|
28.40 |
|
0.05 |
0.18% |
-30.41% |
2025-04-17 |
|
Neurocrine Biosciences
|
101.38 |
|
1.28 |
1.28% |
-23.51% |
2025-04-17 |
|
Pfizer
|
22.25 |
|
0.12 |
0.54% |
-12.37% |
2025-04-18 |
|
Prothena
|
9.20 |
|
-0.06 |
-0.65% |
-55.27% |
2025-04-17 |
|
Ultragenyx Pharmaceutical
|
35.69 |
|
0.71 |
2.03% |
-17.73% |
2025-04-17 |
|
Regeneron Pharmaceuticals
|
563.16 |
|
0.21 |
0.04% |
-37.00% |
2025-04-18 |
|
Repligen
|
130.00 |
|
-2.10 |
-1.59% |
-17.23% |
2025-04-17 |
|
Sarepta Therapeutics
|
53.79 |
|
-0.15 |
-0.28% |
-53.85% |
2025-04-17 |
|
Teva Pharmaceutical Industries
|
5,028.00 |
|
-31.00 |
-0.61% |
1.00% |
2025-04-17 |
|
Vertex Pharmaceuticals
|
489.10 |
|
0.43 |
0.09% |
24.29% |
2025-04-18 |